| 9718800 |
Chromenone derivatives |
Bernard Christophe Barlaam, Sebastien Louis Degorce, Christine Marie Paul Lambert-Van Der Brempt, Remy Robert Morgentin |
2017-08-01 |
$34,361,000 |
| 9029374 |
Chromenone derivatives |
Bernard Christophe Barlaam, Sebastien Louis Degorce, Christine Marie Paul Lambert-Van Der Brempt, Remy Robert Morgentin |
2015-05-12 |
$22,563,000 |
| 8673906 |
Chromenone derivatives |
Bernard Christophe Barlaam, Sebastien Louis Degeorge, Christine Marie Paul Lambert-Van Der Brempt, Remy Robert Morgentin |
2014-03-18 |
$11,307,000 |
| 8569298 |
Pyridine compounds |
Bernard Christophe Barlaam, Kevin Michael Foote, Clifford David Jones |
2013-10-29 |
$11,178,000 |
| 8530470 |
Chromenone derivatives |
Bernard Christophe Barlaam, Sebastien Louis Degorce, Christine Marie Paul Lambert-Van Der Brempt, Jean-Jacques Marcel Lohmann |
2013-09-10 |
$11,273,000 |
| 8492560 |
Quinazoline derivatives as angiogenesis inhibitors |
Elaine Sophie Elizabeth Stokes, Darren McKerrecher, Laurent Francois Andre Hennequin |
2013-07-23 |
$10,935,000 |
| 8399460 |
Chromenone derivatives |
Bernard Chistrophe Barlaam, Sebastien Louis Degorce, Christine Marie Paul Lambert-Van Der Brempt, Remy Robert Morgentin |
2013-03-19 |
$6,069,000 |
| 8153643 |
Quinazoline derivatives |
Frederic H. Jung |
2012-04-10 |
$4,704,000 |
| 7973164 |
Quinoline derivatives |
Frederic H. Jung |
2011-07-05 |
$10,078,000 |
| 7696214 |
Quinazoline derivatives for the treatment of tumours |
Laurent Francois Andre Hennequin |
2010-04-13 |
$6,018,000 |
| 7498335 |
Method of producing an antiangiogenic or vascular permeability reducing effect |
Laurent Francois Andre Hennequin, Graham C. Crawley, Darren McKerrecher, Jeffrey Philip Poyser, Christine Marie Paul Lambert |
2009-03-03 |
$6,549,000 |
| 7462623 |
Quinazoline derivatives as Src tyrosine kinase inhibitors |
— |
2008-12-09 |
$18,199,000 |
| 7141577 |
Quinazoline derivatives |
— |
2006-11-28 |
$25,034,000 |
| 7115615 |
Quinazoline derivatives |
Laurent Francois Andre Hennequin, Christine Marie Paul Lambert |
2006-10-03 |
$22,289,000 |
| 7074800 |
Quinazoline derivatives as angiogenesis inhibitors |
Elaine Sophie Elizabeth Stokes, Darren McKerrecher, Laurent Francois Andre Hennequin |
2006-07-11 |
$7,343,000 |
| 7049438 |
Quinazoline derivatives for treatment of tumours |
Laurent Francois Andre Hennequin |
2006-05-23 |
$9,378,000 |
| 6939866 |
Quinazoline derivatives |
Christine Marie Paul Lambert |
2005-09-06 |
$13,785,000 |
| 6849625 |
Quinazoline derivatives with anti-tumour activity |
Christine Marie Paul Lambert |
2005-02-01 |
$15,421,000 |
| 6809097 |
Quinoline derivatives inhibiting the effect of growth factors such as VEGF |
Andrew Peter Thomas, Laurent Francois Andre Hennequin |
2004-10-26 |
$5,092,000 |
| 6806274 |
Quinazoline derivatives |
Graham C. Crawley, Laurent Francois Andre Hennequin, Darren McKerrecher, Jeffrey Philip Poyser, Christine Marie Paul Lambert |
2004-10-19 |
$7,254,000 |
| 6294532 |
Oxindolylquinazoline derivatives as angiogenesis inhibitors |
Andrew Peter Thomas, Jean-Jacques Marcel Lohmann, Laurent Francois Andre Hennequin |
2001-09-25 |
$16,536,000 |
| 6265411 |
Oxindole derivatives |
Andrew Peter Thomas, Jean-Jacques Marcel Lohmann, Laurent Francois Andre Hennequin |
2001-07-24 |
$6,904,000 |
| 5512594 |
Ether derivatives having 5-lipoxygenase inhibitory activity |
Thomas G. C. Bird, Graham C. Crawley, Michael S. Large |
1996-04-30 |
$1,299,000 |
| 5482966 |
Oxime derivatives |
Thomas G. C. Bird |
1996-01-09 |
$1,178,000 |
| 5478842 |
Ether derivatives having 5-lipoxygenase inhibitory activity |
Thomas G. C. Bird, Graham C. Crawley, Michael S. Large |
1995-12-26 |
$696,000 |
